世界のがん遺伝子治療市場規模・予測2017-2025:エンドユーザー別(診断センター、病院、研究機関)、治療別(腫瘍溶解性ウイルス療法、遺伝子誘導免疫治療、遺伝子導入・その他)、地域別

【英語タイトル】Global Cancer Gene Therapy Market Size Study, By End-User (Diagnostics Centers, Hospitals, Research Institutes), By Therapy (Oncolytic Virotherapy, Gene induced immunotherapy, Gene transfer and others), and Regional Forecasts, 2017-2025 (USD Billion/Million)

Bizwit Research & Consultingが出版した調査資料(BZW803145)・商品コード:BZW803145
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2018年1月29日
・ページ数:70-80
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single UserUSD3,150 ⇒換算¥355,950見積依頼/購入/質問フォーム
Corporate UserUSD5,550 ⇒換算¥627,150見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Bizwit Researchが発行した当調査レポートでは、世界のがん遺伝子治療市場について調査・分析し、世界のがん遺伝子治療市場規模、種類別分析、セグメント別分析、地域別分析(アメリカ市場、アジア市場、ヨーロッパ市場など)、市場動向、世界のがん遺伝子治療関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

Global Cancer Gene Therapy Market industry valued approximately USD 0.2 billion in 2016 is anticipated to grow with a healthy growth rate of more than 35.1% over the forecast period 2017-2025. The major factors driving the growth are rising need for Cancer Gene Therapy worldwide, increase in prevalence of cancer, increase in geriatric population, increase in funding for R&D activities of cancer gene therapy and favorable government regulations.
The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

End-User:
 Diagnostics Centers
 Hospitals
 Research Institutes

Therapy:
 Oncolytic Virotherapy
 Gene Induced Immunotherapy
 Gene transfer
 Others

Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are OncoGenex Pharmaceuticals, Adaptimmune,
Merck, Bluebird bio, Inc,GlaxoSmithKline, Shanghai Sunway Biotech, BioCancell, Celgene, Shenzhen SiBiono GeneTech and SynerGene Therapeutics.Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and focuses on continuous technology innovations are also strategies adopted by the major players. The companies are also trying to dominate the market by investing in research and development.

Target Audience of the Cancer Gene Therapy Market Study

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

【レポートの目次】

Chapter 1. Research Methodology
1.1. Research Process
1.1.1. Data Mining
1.1.2. Analysis
1.1.3. Market Estimation
1.1.4. Validation
1.1.5. Publishing
1.2. Research Assumption
Chapter 2. Global Cancer Gene Therapy Market Definition & Scope
2.1. Objective of The Study
2.2. Market Definition
2.3. Scope of The Study
2.4. Years Considered for The Study
2.5. Currency Conversion Rates
2.6. Report Limitation
Chapter 3. Executive Summary
3.1. Key Trends
3.2. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)
Chapter 4. Global Cancer Gene Therapy Industry Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
Chapter 5. Global Cancer Gene Therapy Market by End-User
5.1. Market Snapshot
5.2. Cancer Gene Therapy Market, Sub Segment Analysis
5.2.1. Diagnostics Centers
5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.2. Hospitals
5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.3. Research Institutes
5.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 6. Global Cancer Gene Therapy Market by Therapy
6.1. Market Snapshot
6.2. Cancer Gene Therapy Market, Sub Segment Analysis
6.2.1. Oncolytic Virotherapy
6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.2. Gene Induced Immunotherapy
6.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.3. Gene Transfer
6.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.4. Others
6.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 7. Global Cancer Gene Therapy Market, Regional Analysis
7.1. Cancer Gene Therapy Market, Regional Market Snapshot (2015-2025)
7.2. North America Cancer Gene Therapy Market Snapshot
7.2.1. U.S. Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.1.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.1.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.2. Canada Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.2.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.2.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.3. Europe Cancer Gene Therapy Market Snapshot
7.3.1. U.K. Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.3.1.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.3.1.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.3.2. Germany Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.3.2.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.3.2.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.3.3. France Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.3.3.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.3.3.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.3.4. Rest of Europe Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.3.4.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.3.4.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.4. Asia Cancer Gene Therapy Market Snapshot
7.4.1. China Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.4.1.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.4.1.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.4.2. India Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.4.2.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.4.2.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.4.3. Japan Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.4.3.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.4.3.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.4.4. Rest of Asia Pacific Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.4.4.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.4.4.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.5. Latin America
7.5.1. Brazil Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.5.1.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.5.1.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.5.2. Mexico Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.5.2.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.5.2.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.6. Rest of The World Cancer Gene Therapy Market Snapshot
7.6.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.6.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.6.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. OncoGenex Pharmaceuticals
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Adaptimmune
8.3.3. Merck
8.3.4. Bluebird bio,Inc
8.3.5. GlaxoSmithKline
8.3.6. Shanghai Sunway Biotech
8.3.7. BioCancell
8.3.8. Celgene
8.3.9. Shenzhen SiBiono GeneTech
8.3.10. SynerGene Therapeutics

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER GENE THERAPY MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER GENE THERAPY MARKET
TABLE 3. GLOBAL CANCER GENE THERAPY MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD MILLION/BILLION)
TABLE 7. GLOBAL CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD MILLION/BILLION)
TABLE 8. GLOBAL CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY APPLICATION 2015-2025 (USD MILLION/BILLION)
TABLE 9. CANCER GENE THERAPY MARKET BY SEGMENT 1, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 10. CANCER GENE THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 11. CANCER GENE THERAPY MARKET BY SEGMENT 2, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 12. CANCER GENE THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 13. CANCER GENE THERAPY MARKET BY SEGMENT 3, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 14. CANCER GENE THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 15. CANCER GENE THERAPY MARKET BY SEGMENT 4, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 16. CANCER GENE THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 17. CANCER GENE THERAPY MARKET BY SEGMENT 5, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 18. CANCER GENE THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 19. CANCER GENE THERAPY MARKET BY SEGMENT 6, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 20. CANCER GENE THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 21. CANCER GENE THERAPY MARKET BY SEGMENT 7, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 22. CANCER GENE THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 23. CANCER GENE THERAPY MARKET BY SEGMENT 8, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 24. CANCER GENE THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 25. CANCER GENE THERAPY MARKET BY SEGMENT 9, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 26. CANCER GENE THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 27. CANCER GENE THERAPY MARKET BY SEGMENT 10, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 28. CANCER GENE THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 29. CANCER GENE THERAPY MARKET BY SEGMENT 11, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 30. CANCER GENE THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 31. U.S. CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 32. U.S. CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 33. U.S. CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 34. CANADA CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 35. CANADA CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 36. CANADA CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 37. UK CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 38. UK CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 39. UK CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 40. GERMANY CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 41. GERMANY CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 42. GERMANY CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 43. ROE CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 44. ROE CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 45. ROE CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 46. CHINA CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 47. CHINA CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 48. CHINA CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 49. INDIA CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 50. INDIA CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 51. INDIA CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 52. JAPAN CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 53. JAPAN CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 54. JAPAN CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 55. ROAPAC CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 56. ROAPAC CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 57. ROAPAC CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 E 2015-2025 (USD MILLION/BILLION)
TABLE 58. BRAZIL CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 59. BRAZIL CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 60. BRAZIL CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 61. MEXICO CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 62. MEXICO CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT1 2015-2025 (USD MILLION/BILLION)
TABLE 63. MEXICO CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 64. ROLA CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 65. ROLA CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 66. ROLA CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 67. ROW CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 68. ROW CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 69. ROW CANCER GENE THERAPY MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)


★調査レポート[世界のがん遺伝子治療市場規模・予測2017-2025:エンドユーザー別(診断センター、病院、研究機関)、治療別(腫瘍溶解性ウイルス療法、遺伝子誘導免疫治療、遺伝子導入・その他)、地域別] (コード:BZW803145)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のがん遺伝子治療市場規模・予測2017-2025:エンドユーザー別(診断センター、病院、研究機関)、治療別(腫瘍溶解性ウイルス療法、遺伝子誘導免疫治療、遺伝子導入・その他)、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆